Dr. Jitendra Singh Unveils Phase 3 of Biomedical Research Career Program
Dr. Jitendra Singh launched phase 3 of the Biomedical Research Career Programme (BRCP), backed by DBT and Wellcome Trust, to strengthen India's biomedical workforce and support a USD 300 billion bioeconomy by 2030.
- Biotechnology | 16/07/2026 | By News Bureau
Interviews
Sachin Joshi, Managing Director and Co-Founder, PharmNXT
Sachin Joshi, Managing Director and Co-Founder, PharmNXT, discusses biologics supply chains, single-use technologies, localisation, and the future of biologics manufacturing, in an exclusive interview with Pharma In...
Greg Killian, SVP and Global Head-Life Sciences and Health Care Business, EPAM Systems
Organisations are increasingly leveraging Artificial Intelligence (AI), data, and digital engineering to drive innovation and operational excellence. Greg Killian, Senior Vice President (SVP) and Global Head–L...
Arushi Jain, Director, Akums Drugs & Pharmaceuticals
Arushi Jain, Director, Akums Drugs & Pharmaceuticals, shares her insights with Pharma Industrial India on pharma inspection readiness, quality assurance, automation, data analytics, and digital transformation in...
Articles
Building the Future of Pharma with AI CoEs and Predictive Manufacturing
Artificial Intelligence (AI) Centers of Excellence (CoEs), predictive manufacturing, and digital twins are reshaping pharma operations by enabling smarter, connected, and future-ready manufacturing ecosystems....
Why India Must Invest More in Novel Drug Discovery
India’s pharma industry must shift from volume to value by investing in novel drug discovery, innovation, and research and development (R&D) to drive global leadership and sustainable growth....
Why Strong Sales Teams are Critical to Pharma Manufacturing Success
Strong sales teams drive pharma success. Artificial Intelligence (AI)-powered training, data insights, and better sales enablement boost market....
Blog
Building a Resilient Pharma Supply Chain in India: Challenges, Innovations and the Road Ahead
By Darshana Daga
PRIP Scheme Set for Rollout: Key Highlights of the INR 5,000 Cr Initiative
By Pharma Industrial India
Latest news in...
Quality / GMP
- - Can-Fite BioPharma Secures Australian Patent for Namodenoson in Advanced Metastatic Cancer
- - TolerogenixX Secures EU Orphan Drug Designation for MIC-Lx in Living-Donor Kidney Transplantation
- - China Grants Priority Review to Leads Biolabs' Opamtistomig for Advanced Neuroendocrine Carcinoma
- - OKYO Pharma Receives FDA Support to Advance Urcosimod into Global Phase 3 Trial
Next events
Appointments
Saumen Chakraborty, Member Board of Directors, PREMAS BIOTECH
Premas Biotech announced the appointment of Saumen Chakraborty to the Premas Biotech Board of Directors. “I am delighte...
Silvia Steyrer-Grube, Chief Executive Officer, CEO, Coriolis Pharma
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development o...
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy